Description
Retatrutide is a high-interest investigational peptide studied for its activity as a triple hormone receptor agonist, targeting the GIP receptor (GIPR), GLP-1 receptor (GLP-1R), and glucagon receptor (GCGR). In the published literature, it is consistently described as a single-molecule triple agonist, which is what makes it distinct from dual incretin compounds such as tirzepatide.
Additional information
| Concentration | 5mg, 10mg, 15mg, 20mg, 30mg, 40mg |
|---|



Reviews
There are no reviews yet.